journal article Open Access Jan 01, 2015

Current and emerging treatment options for&nbsp;ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents

Petar Lenert Aleksander Lenert

Drug Design, Development and Therapy pp. 333 · Informa UK Limited

View at Publisher Save 10.2147/dddt.s67264

Topics

No keywords indexed for this article. Browse by subject →

Metrics

41

Citations

0

References

Details

Published: Jan 01, 2015
Pages: 333
License: View

Authors

Aleksander Lenert

Division of Immunology, Department of Internal Medicine, Carver College of Medicine University of Iowa Hospitals & Clinics Iowa City

Cite This Article

Petar Lenert, Aleksander Lenert (2015). Current and emerging treatment options for&nbsp;ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents. Drug Design, Development and Therapy, 333. https://doi.org/10.2147/dddt.s67264

Related

You May Also Like

Current development of biodegradable polymeric materials for biomedical applications

Richard Song, Maxwell Murphy · 2018

816 citations

Anti-Inflammatory Effects of Curcumin in the Inflammatory Diseases: Status, Limitations and Countermeasures

Ying Peng, Mingyue Ao · 2021

674 citations

8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications

Virapong Prachayasittikul, Veda Prachayasittikul · 2013

385 citations

Linezolid: a review of its properties, function, and use in critical care

Seyed Mohammadreza Hashemian, Tayebeh Farhadi · 2018

381 citations

Baicalin Alleviates Oxidative Stress and Inflammation in Diabetic Nephropathy via Nrf2 and MAPK Signaling Pathway

Leyi Ma, Fan Wu · 2021

237 citations